Podimetrics

Podimetrics develops and markets the FDA-cleared SmartMat™, an at-home thermographic sensor mat that enables early identification—and thus prevention—of diabetic foot ulcers through daily temperature scans analyzed remotely by a dedicated nurse support team. Their solution integrates advanced device technology with personalized virtual care to reduce costly amputations among high-risk individuals living with complex diabetes. The company partners broadly across U.S.-based payors/providers/employers—including VHA/Kaiser Permanente—and has demonstrated strong real-world results including reduced hospitalizations/amputations/costs validated by peer-reviewed studies and large-scale deployments.